BeStock  
Stocks › Medical Devices › IART

Integra Lifesciences IART

US equityMarket cap rank #3233Medical DevicesBrain-Computer Interface
$13.00 −$0.32 (-2.40%)
Pre-market · Oct 8, 8:20 am ET · After hours $13.00 0.00%
Open$13.19
Prev close$13.32
Day range$12.98 – $13.46
Volume1.41M
Market cap$1.01B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±12.8%last 16 reports
Closed higher5 of 1631% of the time
Best reaction+25.1%
Worst reaction-23.5%

Stock move on the day after each report

-5.0%2023/Q3-12.6%2023/Q4-19.9%2024/Q1-19.1%2024/Q2+25.1%2024/Q3+12.1%2024/Q4-21.2%2025/Q1+6.2%2025/Q2-23.5%2025/Q3-2.2%2025/Q4+24.1%2026/Q1-16.5%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q229 Jul 2026Pre Market±13.0%-16.55%Bigger than priced
2026/Q15 May 2026Pre Market±27.8%+24.13%Within range
2025/Q426 Feb 2026Pre Market±19.6%-2.24%Within range
2025/Q330 Oct 2025Pre Market±22.3%-23.46%Bigger than priced
2025/Q231 Jul 2025Pre Market±17.1%+6.22%Within range
2025/Q15 May 2025Pre Market–-21.19%–
2024/Q425 Feb 2025Pre Market±16.5%+12.11%Within range
2024/Q34 Nov 2024Pre Market±15.5%+25.10%Bigger than priced
2024/Q229 Jul 2024Pre Market±17.9%-19.12%Bigger than priced
2024/Q16 May 2024Pre Market±19.0%-19.90%Bigger than priced
2023/Q428 Feb 2024Pre Market±9.1%-12.65%Bigger than priced
2023/Q325 Oct 2023Pre Market±11.7%-4.99%Within range
2023/Q227 Jul 2023Pre Market±10.7%-2.22%Within range
2023/Q126 Apr 2023Pre Market±10.8%-7.89%Within range
2022/Q422 Feb 2023Pre Market±11.8%-1.16%Within range
2022/Q326 Oct 2022Pre Market–+5.85%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Specialty Surgery$309.27M 73.9%
  • Tissue Reconstruction$109.49M 26.1%

Latest reported quarter: Q2, ended Jun 2026

Revenue$418.76M+0.8% YoY
Operating profit$19.29M+1,573.3% YoY
Net profit$4.48M+100.9% YoY
Diluted EPS$0.06+101.0% YoY
Free cash flow$10.50M+193.5% YoY
Operating cash flow$22.80M

Revenue, last 8 quarters

$380.8MSep '24$442.6MDec '24$382.7MMar '25$415.6MJun '25$402.1MSep '25$434.9MDec '25$391.9MMar '26$418.8MJun '26

Net profit, last 8 quarters

$-10.7MSep '24$19.4MDec '24$-25.3MMar '25$-484.1MJun '25$-5.4MSep '25$-1.7MDec '25$-4.6MMar '26$4.5MJun '26

Profitability & balance sheet

Gross margin52.5%
Operating margin4.0%
Net margin-0.4%
Return on equity-0.7%
Return on assets-0.2%
Return on invested capital1.2%
Current ratio3.60
Liabilities / assets70.7%
Cash & investments$274.08M
Total debt$2.03B
Net cash (debt)-$1.76B
Free cash flow / sales0.7%

Discussion

No comments yet — be the first to weigh in on IART.

Leave a comment

Scroll to Top